Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis

Leukemia Research

Volumn 31, Issue 1, 2007, Pages 113-116

  Schwonzen, Martin ^a   Diehl, Volker ^b   Dellanna, Mario ^b   Staib, Peter ^b  

^a St Walburga Krankenhaus   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Acute myeloid leukemia; Density gradient separation; Flow cytometry; Immunophenotyping; Whole blood lysis

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD2 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; GLYCOPHORIN A; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; MEMBRANE ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DENSITY GRADIENT CENTRIFUGATION; ERYTHROCYTE; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, SURFACE; FLOW CYTOMETRY; GLYCOPHORIN; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED;

EID: 33750734260     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.03.022     Document Type: Article

References (23)

1. Catovsky D., Matutes E., Buccheri V., et al. Classification of acute leukaemia for the 1990s. Ann Hematol 62 (1991) 16-21
2. Jennings C.D., and Foon K.A. Recent advances in flow ctyometry: application to the diagnosis of hematologic malignancy. Blood 90 (1997) 2863-2892
3. Bene M.C., Bernier M., Castoldi G., et al. Impact of immunophenotyping on management of acute leukemias. Haematologica 84 (1999) 1024-1034
4. Graeves M.F., Janossy G., Peto J., and Kay H. Immunological defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol 48 (1981) 179-197
5. Knapp W. Monoclonal antibodies against differentiation antigens of myelopoiesis. Blut 45 (1982) 301-308
6. Cordell J.L., Falini B., Erber W.N., et al. Immunoenzymatic labeling of monoclonal antibodies using immune complex of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32 (1984) 219-229
7. Erber W.N., and Mason D.Y. Immunoalkaline phosphatase labeling of terminal transferase in haematologic samples. Am J Clin Pathol 88 (1988) 43-50
8. Davey F.R., Erber W.N., Gatter K.C., and Mason D.Y. Immunophenotyping of acute myeloid leukemia by immuno-alkaline phosphatase (APAAP) labeling with a panel of antibodies. Am J Haematol 26 (1997) 157-166
9. Renzi P., and Ginns L.C. Analysis of T cell subsets in normal adults. Comparison of whole blood lysis technique to Ficoll-Hypaque separation by flow cytometry. J Immunol Meth 2 (1987) 53-56
10. Bene M.C., Castoldi G., Knapp W., et al. Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL). Leukemia 9 (1995) 1783-1786
11. Schwonzen M., Kuehn N., Vetten B., Diehl V., and Pfreundschuh M. Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): association of T-cell-related antigens and skin-infiltration in AMOL. Leukemia Res 13 (1989) 893-898
12. Tamul K.R., Schmitz J.L., Kane K., and Folds J.D. Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies. Clin Diagn Lab Immunol 2 (1995) 337-342
13. Griffin J.D., Linch D., Sabbath K., Larcom P., and Schlossmann F. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cell. Leukemia Res 8 (1984) 521-534
14. Pombo de Oliveira M.S., Matutes E., Sudha Rani Morilla R., and Catovsky D. Early expresssion of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukemia. Acta Haematol 80 (1988) 61-64
15. Scott C.S., Richards S.J., Master P.S., Kendall J., Limbert H.J., and Roberts B.E. Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukaemia: relationships with monocytic subtypes and the concept of relative antigen expression. Eur J Haematol 44 (1999) 24-29
16. Borowitz M.J., Guenther K.L., Shults K.E., and Stelzer G.T. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100 (1993) 534-540
17. Lacombe F., Durrieu F., Briais A., et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 11 (1997) 1878-1886
18. Chang H., Salma F., Yi O.L., Patterson B., Brien B., and Minden M.D. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. Leukemia Res 28 (2004) 43-48
19. Kern W., Voskova D., Schnittger S., Schoch C., Hiddemann W., and Haferlach T. Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukaemia. Hematol J 5 (2004) 410-418
20. Creutzig U., Harbott J., Sperling C., et al. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood 86 (1995) 3097-3108
21. Paietta E., et al. Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials. Leukemia 17 (2003) 1544-1550
22. Bene M.C., et al. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. Blood 92 (1998) 596-599
23. Schwartz S., Heinecke A., Zimmermann M., et al. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance. Leukemia Lymphoma 34 (1999) 85-94